Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
National clinical trials, phase III, randomized, open, parallel, study of superiority, in which three hundred thirty-six (336) participants of both sexes, aged between 18 and 65 years will be randomly allocated to one of two treatment groups. The Group 01 will use Cefalium® and group 02 will use Tylenol®.
Epistemonikos ID: 2a0d8d4e384f9752655b8f1e29c95ba3499558e2
First added on: May 12, 2024